Trial Profile
A phase I trial investigating Iomab-B [anti-CD45-monoclonal-antibody-BC8-I-131] in patients with Non-Hodgkin's-lymphoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs I-131-Apamistamab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 29 Mar 2016 New trial record